Updates on Age to Start and Stop Colorectal Cancer Screening: Recommendations From the U.S. Multi-Society Task Force on Colorectal Cancer

This document is a focused update to the 2017 colorectal cancer (CRC) screening recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer, which represents the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastroint...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Gastroenterology (New York, N.Y. 1943) Ročník 162; číslo 1; s. 285
Hlavní autoři:	Patel, Swati G, May, Folasade P, Anderson, Joseph C, Burke, Carol A, Dominitz, Jason A, Gross, Seth A, Jacobson, Brian C, Shaukat, Aasma, Robertson, Douglas J
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.01.2022
Témata:	Adenocarcinoma - epidemiology Adenocarcinoma - pathology Age Factors Aged Aged, 80 and over Clinical Decision-Making Colonoscopy - adverse effects Colonoscopy - standards Colorectal Neoplasms - epidemiology Colorectal Neoplasms - pathology Consensus Early Detection of Cancer - adverse effects Early Detection of Cancer - standards Female Humans Incidence Male Middle Aged Precancerous Conditions - epidemiology Precancerous Conditions - pathology Predictive Value of Tests Risk Assessment Risk Factors United States - epidemiology United States
ISSN:	1528-0012, 1528-0012
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	This document is a focused update to the 2017 colorectal cancer (CRC) screening recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer, which represents the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. This update is restricted to addressing the age to start and stop CRC screening in average-risk individuals and the recommended screening modalities. Although there is no literature demonstrating that CRC screening in individuals under age 50 improves health outcomes such as CRC incidence or CRC-related mortality, sufficient data support the U.S. Multi-Society Task Force to suggest average-risk CRC screening begin at age 45. This recommendation is based on the increasing disease burden among individuals under age 50, emerging data that the prevalence of advanced colorectal neoplasia in individuals ages 45 to 49 approaches rates in individuals 50 to 59, and modeling studies that demonstrate the benefits of screening outweigh the potential harms and costs. For individuals ages 76 to 85, the decision to start or continue screening should be individualized and based on prior screening history, life expectancy, CRC risk, and personal preference. Screening is not recommended after age 85.
AbstractList	This document is a focused update to the 2017 colorectal cancer (CRC) screening recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer, which represents the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. This update is restricted to addressing the age to start and stop CRC screening in average-risk individuals and the recommended screening modalities. Although there is no literature demonstrating that CRC screening in individuals under age 50 improves health outcomes such as CRC incidence or CRC-related mortality, sufficient data support the U.S. Multi-Society Task Force to suggest average-risk CRC screening begin at age 45. This recommendation is based on the increasing disease burden among individuals under age 50, emerging data that the prevalence of advanced colorectal neoplasia in individuals ages 45 to 49 approaches rates in individuals 50 to 59, and modeling studies that demonstrate the benefits of screening outweigh the potential harms and costs. For individuals ages 76 to 85, the decision to start or continue screening should be individualized and based on prior screening history, life expectancy, CRC risk, and personal preference. Screening is not recommended after age 85.This document is a focused update to the 2017 colorectal cancer (CRC) screening recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer, which represents the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. This update is restricted to addressing the age to start and stop CRC screening in average-risk individuals and the recommended screening modalities. Although there is no literature demonstrating that CRC screening in individuals under age 50 improves health outcomes such as CRC incidence or CRC-related mortality, sufficient data support the U.S. Multi-Society Task Force to suggest average-risk CRC screening begin at age 45. This recommendation is based on the increasing disease burden among individuals under age 50, emerging data that the prevalence of advanced colorectal neoplasia in individuals ages 45 to 49 approaches rates in individuals 50 to 59, and modeling studies that demonstrate the benefits of screening outweigh the potential harms and costs. For individuals ages 76 to 85, the decision to start or continue screening should be individualized and based on prior screening history, life expectancy, CRC risk, and personal preference. Screening is not recommended after age 85. This document is a focused update to the 2017 colorectal cancer (CRC) screening recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer, which represents the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. This update is restricted to addressing the age to start and stop CRC screening in average-risk individuals and the recommended screening modalities. Although there is no literature demonstrating that CRC screening in individuals under age 50 improves health outcomes such as CRC incidence or CRC-related mortality, sufficient data support the U.S. Multi-Society Task Force to suggest average-risk CRC screening begin at age 45. This recommendation is based on the increasing disease burden among individuals under age 50, emerging data that the prevalence of advanced colorectal neoplasia in individuals ages 45 to 49 approaches rates in individuals 50 to 59, and modeling studies that demonstrate the benefits of screening outweigh the potential harms and costs. For individuals ages 76 to 85, the decision to start or continue screening should be individualized and based on prior screening history, life expectancy, CRC risk, and personal preference. Screening is not recommended after age 85.
Author	Dominitz, Jason A Jacobson, Brian C May, Folasade P Anderson, Joseph C Burke, Carol A Robertson, Douglas J Gross, Seth A Patel, Swati G Shaukat, Aasma
Author_xml	– sequence: 1 givenname: Swati G surname: Patel fullname: Patel, Swati G email: swati.patel@cuanschutz.edu organization: University of Colorado Anschutz Medical Center, Aurora, Colorado; Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado. Electronic address: swati.patel@cuanschutz.edu – sequence: 2 givenname: Folasade P surname: May fullname: May, Folasade P organization: Division of Gastroenterology, Department of Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California; Vatche and Tamar Manoukian Division of Digestive Diseases and Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, California – sequence: 3 givenname: Joseph C surname: Anderson fullname: Anderson, Joseph C organization: VA Medical Center, White River Junction, Vermont, and the Geisel School of Medicine at Dartmouth, Hanover, New Hampshire; University of Connecticut School of Medicine, Farmington, Connecticut – sequence: 4 givenname: Carol A surname: Burke fullname: Burke, Carol A organization: Cleveland Clinic, Cleveland, Ohio – sequence: 5 givenname: Jason A surname: Dominitz fullname: Dominitz, Jason A organization: VA Puget Sound Health Care System and the University of Washington, Seattle, Washington – sequence: 6 givenname: Seth A surname: Gross fullname: Gross, Seth A organization: NYU Langone Health, New York, New York – sequence: 7 givenname: Brian C surname: Jacobson fullname: Jacobson, Brian C organization: Massachusetts General Hospital, Boston, Massachusetts – sequence: 8 givenname: Aasma surname: Shaukat fullname: Shaukat, Aasma organization: GI Section, Minneapolis VA Medical Center and University of Minnesota, Minneapolis, Minnesota – sequence: 9 givenname: Douglas J surname: Robertson fullname: Robertson, Douglas J organization: VA Medical Center, White River Junction, Vermont, and the Geisel School of Medicine at Dartmouth, Hanover, New Hampshire
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/34794816$$D View this record in MEDLINE/PubMed
BookMark	eNplkN9KwzAUxoNM3B99A5FcetOapGmbejeGU2Ei2O26pOnZ7GyTmqQXewTf2g4nCHIuzsfh43e-c6ZopI0GhK4pCSmJo7t9uJPOWxMywugwCglJz9CExkwEhFA2-qPHaOrcnhCSRYJeoHHE04wLmkzQ16arpAeHjcbzHWBvcO6l9VjqalCmwwvTGAvKywYvpFZgca4sgK717h6_gTJtC3pg1EY7vLSmxf4d8CbMQ_zSN74OcqNq8Ae8lu4DL41VcFz2D3uJzreycXB16jO0WT6sF0_B6vXxeTFfBWpI7AMhYMtiopKYJlylrKRpmlbDjTyjSkSCqTLh26EixlXGaVnxmAoAKKu4opKwGbr94XbWfPbgfNHWTkHTSA2mdwWLs4wKFpGj9eZk7csWqqKzdSvtofh9H_sGewV1DA
CitedBy_id	crossref_primary_10_1097_MCG_0000000000002072 crossref_primary_10_3390_gidisord5010004 crossref_primary_10_3238_arztebl_m2025_0018 crossref_primary_10_7759_cureus_84724 crossref_primary_10_1016_j_gim_2022_08_027 crossref_primary_10_5812_zjrms_133328 crossref_primary_10_3390_diagnostics14232762 crossref_primary_10_7326_M24_0080 crossref_primary_10_5009_gnl250010 crossref_primary_10_1016_j_cgh_2022_12_006 crossref_primary_10_2147_OTT_S454295 crossref_primary_10_1055_a_2245_6526 crossref_primary_10_1016_j_pop_2024_12_007 crossref_primary_10_1111_ajco_14184 crossref_primary_10_1186_s12876_024_03177_z crossref_primary_10_1097_DCR_0000000000002947 crossref_primary_10_3390_jcm13102887 crossref_primary_10_3390_cancers15113006 crossref_primary_10_1080_08998280_2024_2342723 crossref_primary_10_3390_cancers16193363 crossref_primary_10_1007_s00384_023_04470_1 crossref_primary_10_1053_j_gastro_2025_01_017 crossref_primary_10_3390_cancers17172820 crossref_primary_10_3390_diagnostics12092070 crossref_primary_10_1111_ans_19221 crossref_primary_10_1053_j_gastro_2023_11_305 crossref_primary_10_14309_ajg_0000000000002174 crossref_primary_10_1016_j_esmogo_2025_100181 crossref_primary_10_1016_j_cgh_2022_04_037 crossref_primary_10_3389_fonc_2024_1337035 crossref_primary_10_1016_j_gtc_2022_05_002 crossref_primary_10_1053_j_gastro_2022_08_011 crossref_primary_10_1016_j_tige_2023_01_008 crossref_primary_10_1371_journal_pone_0304374 crossref_primary_10_1002_cam4_6880 crossref_primary_10_1007_s00394_022_02993_x crossref_primary_10_3390_healthcare12161645 crossref_primary_10_1016_j_tige_2024_02_002 crossref_primary_10_1111_jgh_16468 crossref_primary_10_1016_j_focus_2024_100296 crossref_primary_10_1016_j_suc_2023_12_003 crossref_primary_10_1136_gutjnl_2022_327211 crossref_primary_10_1016_j_cgh_2022_12_026 crossref_primary_10_1038_s41572_023_00432_7 crossref_primary_10_1016_j_amepre_2025_107654 crossref_primary_10_14309_ctg_0000000000000878 crossref_primary_10_1001_jamanetworkopen_2024_29645 crossref_primary_10_1371_journal_pone_0295900 crossref_primary_10_1200_JCO_25_00148 crossref_primary_10_36290_vnl_2024_095 crossref_primary_10_1080_08998280_2024_2303529 crossref_primary_10_1002_cac2_70059 crossref_primary_10_1097_MCG_0000000000001967 crossref_primary_10_1001_jama_2025_7515 crossref_primary_10_3390_jcm13040937 crossref_primary_10_1093_clinchem_hvad198 crossref_primary_10_1001_jamanetworkopen_2024_10123 crossref_primary_10_1186_s12889_024_20095_7 crossref_primary_10_7326_L24_0012 crossref_primary_10_14309_ajg_0000000000002536 crossref_primary_10_1016_j_cgh_2022_07_028 crossref_primary_10_1136_gutjnl_2023_329429 crossref_primary_10_1177_10815589231193953 crossref_primary_10_1007_s00384_025_04805_0 crossref_primary_10_3393_ac_2023_00367_0052 crossref_primary_10_1056_NEJMoa2304714 crossref_primary_10_1016_j_jss_2024_05_036 crossref_primary_10_1053_j_gastro_2022_01_041 crossref_primary_10_1097_MCG_0000000000001855 crossref_primary_10_1001_jamanetworkopen_2024_47806 crossref_primary_10_1055_a_2272_1911 crossref_primary_10_3748_wjg_v30_i3_211 crossref_primary_10_1016_j_medcle_2024_04_019 crossref_primary_10_1016_j_suc_2023_11_009 crossref_primary_10_1186_s12880_024_01207_6 crossref_primary_10_1007_s00464_025_11871_6 crossref_primary_10_1007_s00535_024_02089_9 crossref_primary_10_1016_j_gie_2022_07_007 crossref_primary_10_14309_ctg_0000000000000730 crossref_primary_10_1016_j_tige_2024_03_001 crossref_primary_10_1177_10815589241296022 crossref_primary_10_1155_2024_9943412 crossref_primary_10_1053_j_gastro_2023_12_027 crossref_primary_10_2478_rjim_2023_0038 crossref_primary_10_1186_s12874_023_02039_8 crossref_primary_10_1016_j_gie_2022_05_015 crossref_primary_10_1158_1940_6207_CAPR_23_0544 crossref_primary_10_1016_j_ijbiomac_2025_145765 crossref_primary_10_1186_s12875_025_02854_6 crossref_primary_10_14309_ajg_0000000000001684 crossref_primary_10_1016_j_arth_2025_08_026 crossref_primary_10_1016_j_asjsur_2025_02_112 crossref_primary_10_7326_M23_3086 crossref_primary_10_1053_j_gastro_2024_05_007 crossref_primary_10_1016_j_gastha_2025_100693 crossref_primary_10_1038_s41420_023_01354_9 crossref_primary_10_1056_NEJMc2404924 crossref_primary_10_1158_1078_0432_CCR_25_0449 crossref_primary_10_1155_2022_4217529 crossref_primary_10_1177_10732748251313499 crossref_primary_10_1001_jamanetworkopen_2023_21730 crossref_primary_10_1016_j_cgh_2024_07_044 crossref_primary_10_1007_s00330_024_10645_3 crossref_primary_10_7759_cureus_72797 crossref_primary_10_1016_j_cgh_2022_05_035 crossref_primary_10_1055_s_0044_1801379 crossref_primary_10_1097_XCS_0000000000000768 crossref_primary_10_1016_j_bpg_2024_101941 crossref_primary_10_1016_j_igie_2023_08_007 crossref_primary_10_1016_j_clcc_2023_01_001 crossref_primary_10_1136_gutjnl_2022_327377 crossref_primary_10_7326_M24_0743 crossref_primary_10_1080_07357907_2024_2315443 crossref_primary_10_1016_j_clinimag_2025_110401 crossref_primary_10_1007_s10552_024_01889_x crossref_primary_10_1007_s12029_025_01257_1 crossref_primary_10_1002_cncr_35097 crossref_primary_10_1016_j_ajg_2025_03_002 crossref_primary_10_1053_j_gastro_2022_05_036 crossref_primary_10_1089_whr_2022_0065 crossref_primary_10_1111_jgh_16491 crossref_primary_10_1016_j_cgh_2022_07_014 crossref_primary_10_1016_j_surg_2024_05_031 crossref_primary_10_1053_j_gastro_2023_02_021 crossref_primary_10_3390_medicina61030390 crossref_primary_10_3390_molecules29071508 crossref_primary_10_1001_jamanetworkopen_2024_13157 crossref_primary_10_1093_ije_dyae123 crossref_primary_10_1038_s41575_022_00612_y crossref_primary_10_3390_cancers16152746 crossref_primary_10_1001_jamanetworkopen_2024_2693 crossref_primary_10_1016_j_nurpra_2022_104537 crossref_primary_10_4251_wjgo_v16_i8_3393 crossref_primary_10_1111_1751_2980_13235 crossref_primary_10_1245_s10434_022_12986_z
ContentType	Journal Article
Copyright	Copyright © 2022 AGA Institute, the American Society for Gastrointestinal Endoscopy, and American College of Gastroenterology. Published by Elsevier Inc. All rights reserved.
Copyright_xml	– notice: Copyright © 2022 AGA Institute, the American Society for Gastrointestinal Endoscopy, and American College of Gastroenterology. Published by Elsevier Inc. All rights reserved.
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1053/j.gastro.2021.10.007
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine
EISSN	1528-0012
ExternalDocumentID	34794816
Genre	Journal Article Practice Guideline Review
GeographicLocations	United States
GeographicLocations_xml	– name: United States
GroupedDBID	--- --K .1- .55 .FO .GJ 0R~ 1B1 1CY 1P~ 1~5 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 AAEDT AAEDW AAIKJ AALRI AAQFI AAQOH AAQQT AAQXK AAXUO AAYOK ABCQX ABDPE ABJNI ABLJU ABMAC ABOCM ABWVN ACRPL ADBBV ADMUD ADNMO ADPAM AENEX AEVXI AFCTW AFFNX AFHKK AFJKZ AFRHN AFTJW AGHFR AI. AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ ASPBG AVWKF AZFZN BELOY BR6 C5W CAG CGR COF CS3 CUY CVF DU5 EBS ECM EFJIC EIF EJD F5P FD8 FDB FEDTE FGOYB GBLVA HVGLF HZ~ IHE J1W J5H K-O KOM L7B M41 MO0 N4W N9A NPM NQ- O9- OC. OHT ON0 P2P PC. PKN QTD R2- RIG ROL RPZ SEL SES SJN SSZ UDS UGJ UV1 VH1 WH7 X7M XH2 Y6R YQJ Z5R ZGI ZXP 7X8 AAFWJ ACVFH ADCNI EFKBS
ID	FETCH-LOGICAL-c481t-88ef250c65164c72b1777d012491c8382cb64f4f4324c941bd4518eeebd5d1a02
IEDL.DBID	7X8
ISICitedReferencesCount	165
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000731332400008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1528-0012
IngestDate	Thu Oct 02 10:40:34 EDT 2025 Wed Feb 19 02:24:26 EST 2025
IsPeerReviewed	true
IsScholarly	true
Issue	1
Language	English
License	Copyright © 2022 AGA Institute, the American Society for Gastrointestinal Endoscopy, and American College of Gastroenterology. Published by Elsevier Inc. All rights reserved.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c481t-88ef250c65164c72b1777d012491c8382cb64f4f4324c941bd4518eeebd5d1a02
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Instructional Material/Guideline-3 ObjectType-Review-4 content type line 23
PMID	34794816
PQID	2599182300
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_2599182300 pubmed_primary_34794816
PublicationCentury	2000
PublicationDate	2022-01-00 20220101
PublicationDateYYYYMMDD	2022-01-01
PublicationDate_xml	– month: 01 year: 2022 text: 2022-01-00
PublicationDecade	2020
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Gastroenterology (New York, N.Y. 1943)
PublicationTitleAlternate	Gastroenterology
PublicationYear	2022
References	35618018 - Gastroenterology. 2022 May 23
References_xml	– reference: 35618018 - Gastroenterology. 2022 May 23;:
SSID	ssj0009381
Score	2.676339
SecondaryResourceType	review_article
Snippet	This document is a focused update to the 2017 colorectal cancer (CRC) screening recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer,...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	285
SubjectTerms	Adenocarcinoma - epidemiology Adenocarcinoma - pathology Age Factors Aged Aged, 80 and over Clinical Decision-Making Colonoscopy - adverse effects Colonoscopy - standards Colorectal Neoplasms - epidemiology Colorectal Neoplasms - pathology Consensus Early Detection of Cancer - adverse effects Early Detection of Cancer - standards Female Humans Incidence Male Middle Aged Precancerous Conditions - epidemiology Precancerous Conditions - pathology Predictive Value of Tests Risk Assessment Risk Factors United States - epidemiology
Title	Updates on Age to Start and Stop Colorectal Cancer Screening: Recommendations From the U.S. Multi-Society Task Force on Colorectal Cancer
URI	https://www.ncbi.nlm.nih.gov/pubmed/34794816 https://www.proquest.com/docview/2599182300
Volume	162
WOSCitedRecordID	wos000731332400008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7qRHzxfpk3IviabUlvqS8iw-LLxmAb7G2kaTpU1ta2-h_8157TduxBBEEKbV6ahuT0nO_cCblzQjhV7QsW88hhIG9tpoQXMmWM0L7h8JRVswlvOJSzmT9qDG5FE1a54okVo45SjTbyLsB0n6NXqPeQvTPsGoXe1aaFxiZpWQBlkKq92bpauG_Jul4qVmEGTrxKnXOs7mtnoYoyx_Q_wTtVfJf3O8ishE2w_99lHpC9BmbSx5ouDsmGSY7IzqBxpB-Tr2mGqn5B04Q-LgwtUwqwMy-pSiIYpRntA1dEbgiz9JEycjrWGKMDou6eotK6XJqmIVNBgzxdUoCSdNoZd2iV1MuaeFA6UcUbDdJcG_zYj2lPyDR4mvSfWdOVgWlb8pJJaWLATdp1QNPSnsD6VV7UwybWXEtLCh26dgwXQDXt2zyMbIdLY0wYORFXPXFKtpI0MeeE9iIgi9j1XWUp21TaVGxE6Flcx47iok1uV5s8B6pHV4ZKTPpRzNfb3CZn9UnNs7o8xxxzY2Gl7sUf3r4kuwLzGSqbyhVpxfDPm2uyrT_LlyK_qcgJ7sPR4BvZO9Ru
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Updates+on+Age+to+Start+and+Stop+Colorectal+Cancer+Screening%3A+Recommendations+From+the+U.S.+Multi-Society+Task+Force+on+Colorectal+Cancer&rft.jtitle=Gastroenterology+%28New+York%2C+N.Y.+1943%29&rft.au=Patel%2C+Swati+G&rft.au=May%2C+Folasade+P&rft.au=Anderson%2C+Joseph+C&rft.au=Burke%2C+Carol+A&rft.date=2022-01-01&rft.issn=1528-0012&rft.eissn=1528-0012&rft.volume=162&rft.issue=1&rft.spage=285&rft_id=info:doi/10.1053%2Fj.gastro.2021.10.007&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1528-0012&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1528-0012&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1528-0012&client=summon